Cybin Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

233.67M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	-	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-
Mar 31, 2021	686.88K	-	-
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Codexis	78.09M
Cellectis	75.11M
Coherus Oncology	46.88M
Voyager Therapeutics	36.49M
Orchestra BioMed Holdings	32.72M
Sol-Gel Technologies	18.47M
Whitehawk Therapeutics	7.15M
Fate Therapeutics	6.32M

Revenue Rankings

HELP News

5 days ago - Cybin Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference - Transcripts
9 days ago - Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference - GlobeNewsWire
15 days ago - Cybin Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
19 days ago - Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
7 weeks ago - CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
7 weeks ago - Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - GlobeNewsWire
7 weeks ago - Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
2 months ago - Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - GlobeNewsWire

More News